Migranal Side Effects
Generic Name: dihydroergotamine
Note: This page contains information about the side effects of dihydroergotamine. Some of the dosage forms included on this document may not apply to the brand name Migranal.
Not all side effects for Migranal may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to dihydroergotamine: nasal spray
In addition to its needed effects, some unwanted effects may be caused by dihydroergotamine (the active ingredient contained in Migranal). In the event that any of these side effects do occur, they may require medical attention.
If any of the following side effects occur while taking dihydroergotamine, check with your doctor or nurse as soon as possible:Less common or rare
- Chest pain
- cough, fever, sneezing, or sore throat
- feeling of heaviness in chest
- irregular heartbeat
- itching of the skin
- numbness and tingling of face, fingers, or toes
- pain in arms, legs, or lower back
- pain in back, chest or left arm
- pale bluish-colored or cold hands or feet
- shortness of breath or troubled breathing
- weak or absent pulses in legs
- convulsions (seizures)
- nausea and/or vomiting
- numbness, tingling, and/or pain in the legs or arms
- shortness of breath
- stomach pain
Some of the side effects that can occur with dihydroergotamine may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:More common
- Burning or tingling sensation, dryness, soreness, or pain in the nose
- change in sense of taste
- dry mouth
- increased sweating
- nausea and or vomiting
- muscle stiffness
- runny and or stuffy nose
- sudden sweatings and feelings of warmth
- sensation of burning, warmth, or heat
- sore throat
- unexplained nose bleeds
- unusual tiredness or weakness
- blurred vision
- cold clammy skin
- congestion in chest
- decreased appetite
- difficulty swallowing
- dizziness or lightheadedness when getting up from a lying or sitting position
- ear pain
- eye pain
- increased watering of eyes
- increased watering of the mouth
- increased yawning
- muscle weakness
- pinpoint red spots on skin
- pounding heartbeat
- red or irritated eyes
- ringing or buzzing in ears
- skin rash
- stomach pain
- sudden fainting
- swelling of face, fingers, feet, or lower legs
- trembling or shaking of hands or feet
- trouble in sleeping
- unusual feeling of well being
For Healthcare Professionals
Applies to dihydroergotamine: injectable solution, nasal spray
Gastrointestinal side effects including nausea, vomiting, and diarrhea have been reported to occur commonly.
The most frequent side effect with the use of intravenous dihydroergotamine is nausea. Following intramuscular or intranasal administration, the incidence of nausea is low.
Other side effects including arterial spasm, sometimes with resulting limb necrosis, have been reported rarely. The incidence is believed to be about 1 to 3 per 100,000 patients treated for thromboprophylaxis.
Musculoskeletal side effects including muscle cramps and weakness have been reported.
Nervous system side effects including drowsiness, restlessness, cerebral arteriopathy, and paresthesias have been reported.
Local side effects including pain, burning, itching, edemas, and hematomas at the site of parenteral administration have been reported to occur commonly.
Cardiovascular side effects including hypertension, tachycardia, bradycardia, precordial distress, and chest pain have been reported. Myocardial ischemia and myocardial infarction have been reported rarely.
Respiratory side effects including pleural fibrosis have been reported following long-term high dose treatment.
Renal side effect including retroperitoneal fibrosis have been reported following long-term high dose treatment.
More about Migranal (dihydroergotamine)
- Other brands: D.H.E. 45
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.